Colloquium C11: Lipid pathways as targets for MS therapy
نویسندگان
چکیده
منابع مشابه
E2F1 death pathways as targets for cancer therapy
Defects in apoptotic programs contribute to a number of human diseases, ranging from neurodegenerative disorders to malignancy, and treatment failure. The genetic basis for apoptosis implies that cell death can be disrupted by mutations, raising the intriguing possibility that cell numbers can be regulated by factors that influence cell survival. It is well documented that the E2F1 transcriptio...
متن کاملEvolving targets for lipid-modifying therapy
The pathogenesis and progression of atherosclerosis are integrally connected to the concentration and function of lipoproteins in various classes. This review examines existing and emerging approaches to modify low-density lipoprotein and lipoprotein (a), triglyceride-rich lipoproteins, and high-density lipoproteins, emphasizing approaches that have progressed to clinical evaluation. Targeting ...
متن کاملMetabolic Pathways as Targets for Drug Screening
In the drug development process, candidate compounds are first screened for desirable biological properties such as effects on gene expression, signal transduction, or enzyme activity. The genetic and metabolic pathways used in the readouts are known as targets of the drug screening process. Despite advances in molecular targeting, proteomics and metabolomics, drug screening with molecular or m...
متن کاملKey pathways as therapeutic targets.
dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol. 2002;63(12):1133-1148. 11. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity. 2008;28(3):402-413. 12. Milpied P, Renand A, Bruneau J, et al. Neuropilin-1 is not a marker of ...
متن کاملApicoplast Biosynthetic Pathways as Possible Targets for Combination Therapy of Malaria
The emergence of malaria parasite strains resistant to practically all the antimalarial drugs in clinical use is now making it necessary to discover and develop both new antimalarial drugs and treatments. Recent advances in molecular techniques along with the availability of genome sequence of Plasmodium falciparum may provide a wide range of novel targets in metabolic pathways like isoprenoid ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurochemistry
سال: 2005
ISSN: 0022-3042,1471-4159
DOI: 10.1111/j.1474-1644.2005.03230_7.x